Axogen, Inc. (AXGN)
31.42
+2.07
(+7.05%)
USD |
NASDAQ |
Dec 17, 16:00
31.42
0.00 (0.00%)
After-Hours: 16:12
Axogen Research and Development Expense (Annual): 27.77M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Phibro Animal Health Corp. | 23.73M |
| IRIDEX Corp. | 5.179M |
| Stereotaxis, Inc. | 9.76M |
| Electromed, Inc. | 0.996M |
| Myomo, Inc. | 4.772M |